Based on 1 Customer Validation
DAPT (GSI-IX) (GMP) is DAPT (HY-13027) produced by using GMP guidelines. GMP small molecules works appropriately as an auxiliary reagent for cell therapy manufacture. DAPT is a potent and orally active γ-secretase inhibitor.
For research use only. We do not sell to patients.
- CAS No.: 208255-80-5
- Formula: C23H26F2N2O4
- Molecular Weight:432.46
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| HEK293 | IC50 |
34200 nM
Compound: DAPT
|
Displacement of [3H]L685458 from human SPP expressed in HEK293 cells
Displacement of [3H]L685458 from human SPP expressed in HEK293 cells
|
[PMID: 17932033] |
| Hep 3B2 | IC50 |
5 μM
Compound: DAPT
|
Cytotoxicity against human Hep3B cells assessed as growth inhibition after 72 hrs by SRB assay
Cytotoxicity against human Hep3B cells assessed as growth inhibition after 72 hrs by SRB assay
|
[PMID: 30108693] |
| Huh-7 | IC50 |
5 μM
Compound: DAPT
|
Cytotoxicity against human HuH7 cells assessed as growth inhibition after 72 hrs by SRB assay
Cytotoxicity against human HuH7 cells assessed as growth inhibition after 72 hrs by SRB assay
|
[PMID: 30108693] |
| Mahlavu | IC50 |
5 μM
Compound: DAPT
|
Cytotoxicity against human Mahlavu cells assessed as growth inhibition after 72 hrs by SRB assay
Cytotoxicity against human Mahlavu cells assessed as growth inhibition after 72 hrs by SRB assay
|
[PMID: 30108693] |
| SNU-475 | IC50 |
0.6 μM
Compound: DAPT
|
Cytotoxicity against human SNU475 cells assessed as growth inhibition after 72 hrs by SRB assay
Cytotoxicity against human SNU475 cells assessed as growth inhibition after 72 hrs by SRB assay
|
[PMID: 30108693] |
| THP-1 | IC50 |
6.3 nM
Compound: DAPT
|
Displacement of [3H]IN973 from gamma-secretase in human THP1 cells
Displacement of [3H]IN973 from gamma-secretase in human THP1 cells
|
[PMID: 17932033] |
| THP-1 | IC50 |
>100000 nM
Compound: DAPT
|
Displacement of [3H]L685458 from gamma-secretase in human THP1 cells
Displacement of [3H]L685458 from gamma-secretase in human THP1 cells
|
[PMID: 17932033] |
In Vitro
DAPT (GMP) (9 d) induces human induced pluripotent stem cells develop into expandable myoblasts[1]. DAPT (GMP) (13 d) induces human pluripotent stem cells (hPSCs) develop into functional neurons[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
Chemical Information
-
CAS No. 208255-80-5
-
Appearance Solid
-
Molecular Weight 432.46
-
Formula C23H26F2N2O4
-
Color White to off-white
-
SMILES
FC1=CC(F)=CC(CC(N[C@H](C(N[C@H](C(OC(C)(C)C)=O)C2=CC=CC=C2)=O)C)=O)=C1
-
Synonyms
GSI-IX (GMP)
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Notch Pathway Solutions
The Notch pathway is a contact-dependent signaling pathway that controls cell-fate decisions, differentiation, proliferation, and tissue patterning through interactions between membrane-bound Notch receptors and membrane-bound ligands on neighboring cells. Canonical Notch signaling is activated when ligand engagement triggers proteolytic release of the Notch intracellular domain, which enters the nucleus and regulates transcription together with DNA-binding transcriptional complexes. In the canonical mechanism, ligand-dependent Notch activation leads to release of the intracellular Notch domain, and presenilin-dependent γ-secretase activity is required for production of the active intracellular signaling fragment. The released intracellular domain functions as a nuclear signal that converts Notch receptor activation at the membrane into transcriptional regulation of target programs such as HES/HEY-family genes and other context-dependent downstream targets. The literature links Notch p
Purity & Documentation
-
Data Sheet (266 KB)
-
SDS (393 KB)
- English - EN (393 KB)
- Français - FR (393 KB)
- Deutsch - DE (393 KB)
- Norwegian - NO (393 KB)
- Español - ES (393 KB)
- Swedish - SV (393 KB)
- Italian - IT (393 KB)
- Korean - KR (393 KB)
- Portuguese - PT (393 KB)
-
Handling Instructions (2659 KB)
References
[1]. Choi IY, et al. Concordant but Varied Phenotypes among Duchenne Muscular Dystrophy Patient-Specific Myoblasts Derived using a Human iPSC-Based Model. Cell Rep. 2016 Jun 7;15(10):2301-2312. [Content Brief]
[2]. Qi Y, et al. Combined small-molecule inhibition accelerates the derivation of functional cortical neurons from human pluripotent stem cells. Nat Biotechnol. 2017 Feb;35(2):154-163. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)